agilon health, inc. (NYSE:AGL) Sees Significant Drop in Short Interest

agilon health, inc. (NYSE:AGL) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 29,790,000 shares, a decline of 6.7% from the November 30th total of 31,940,000 shares. Based on an average daily volume of 4,350,000 shares, the short-interest ratio is presently 6.8 days. Approximately 9.8% of the shares of the company are sold short.

Analyst Ratings Changes

A number of analysts recently weighed in on AGL shares. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Citigroup decreased their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. Finally, Evercore ISI lowered their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Three equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $4.28.

agilon health Stock Down 0.5 %

AGL opened at $1.90 on Thursday. The firm has a market cap of $782.83 million, a P/E ratio of -2.02 and a beta of 0.51. The business’s fifty day simple moving average is $2.14 and its 200 day simple moving average is $3.98. agilon health has a 52 week low of $1.50 and a 52 week high of $13.28. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the business earned ($0.06) earnings per share. As a group, equities research analysts anticipate that agilon health will post -0.52 EPS for the current fiscal year.

Insider Activity

In other news, Director Diana Mckenzie bought 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The stock was bought at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Karen Mcloughlin purchased 25,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 90,000 shares of company stock valued at $198,100. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of New York Mellon Corp boosted its holdings in shares of agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock worth $7,252,000 after purchasing an additional 174,883 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after buying an additional 10,674 shares during the period. Principal Financial Group Inc. lifted its position in agilon health by 42.4% during the second quarter. Principal Financial Group Inc. now owns 41,675 shares of the company’s stock worth $273,000 after buying an additional 12,411 shares during the period. Signaturefd LLC boosted its stake in agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after buying an additional 7,398 shares during the last quarter. Finally, nVerses Capital LLC purchased a new stake in agilon health in the 2nd quarter valued at about $210,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.